IRIS
FASANO, Serena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.338
AS - Asia 923
NA - Nord America 770
SA - Sud America 181
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.221
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.692
US - Stati Uniti d'America 751
IE - Irlanda 313
HK - Hong Kong 257
SG - Singapore 245
CN - Cina 213
BR - Brasile 148
IT - Italia 88
GB - Regno Unito 76
KR - Corea 59
VN - Vietnam 53
DE - Germania 32
IN - India 30
GR - Grecia 27
FR - Francia 26
SE - Svezia 26
UA - Ucraina 22
JP - Giappone 15
AR - Argentina 14
TR - Turchia 12
ES - Italia 9
BD - Bangladesh 8
EC - Ecuador 7
FI - Finlandia 7
CA - Canada 6
MX - Messico 6
PL - Polonia 5
ID - Indonesia 4
IQ - Iraq 4
PT - Portogallo 4
AT - Austria 3
MY - Malesia 3
PA - Panama 3
PK - Pakistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BE - Belgio 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NL - Olanda 2
PY - Paraguay 2
TN - Tunisia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
CR - Costa Rica 1
EU - Europa 1
GL - Groenlandia 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
MA - Marocco 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SR - Suriname 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.221
Salva come PNG Salva come JPEG
Città #
Moscow 572
Dublin 313
Hong Kong 256
Santa Clara 179
Chandler 96
Singapore 82
Jacksonville 69
Seoul 57
Hefei 36
Beijing 34
Princeton 33
Roxbury 32
Medford 24
Ashburn 21
Bremen 20
Ho Chi Minh City 20
Caserta 15
Bengaluru 13
The Dalles 13
Hanoi 12
Cambridge 11
Des Moines 11
São Paulo 10
Dallas 9
Jinan 8
Los Angeles 8
Nanjing 8
New York 8
Pamplona 8
Wilmington 8
Boardman 7
Tokyo 7
Ann Arbor 6
Chennai 6
Guangzhou 6
Haiphong 5
Marseille 5
Naples 5
Rio de Janeiro 5
Da Nang 4
Guayaquil 4
Milan 4
Napoli 4
Sant'Angelo in Formis 4
Shanghai 4
Villa Literno 4
Atlanta 3
Belo Horizonte 3
Brooklyn 3
Buenos Aires 3
Campinas 3
Campo Grande 3
Changsha 3
Chicago 3
Columbus 3
Dhaka 3
Falkenstein 3
Goiânia 3
Hyderabad 3
Marília 3
Shenyang 3
Warsaw 3
Almaty 2
Aparecida de Goiânia 2
Baku 2
Betim 2
Bishkek 2
Boston 2
Brussels 2
Caracas 2
Charleston 2
Essex 2
Guarulhos 2
Gwangju 2
Hebei 2
Jiaxing 2
Johannesburg 2
Juiz de Fora 2
Kraków 2
Krasnodar 2
Kuala Lumpur 2
Lanzhou 2
Lappeenranta 2
Lisbon 2
Lucknow 2
Manaus 2
Mcallen 2
Mexico City 2
Minerbio 2
Mountain View 2
Nanchang 2
Panama City 2
Porto Alegre 2
Redwood City 2
Ribeirão Preto 2
San Mateo 2
Santa Luzia 2
Santiago 2
Santo André 2
Santos 2
Totale 2.190
Salva come PNG Salva come JPEG
Nome #
Biologic treatments for idiopathic inflammatory myopathies 183
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 131
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 129
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 129
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 116
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 112
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 111
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 111
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. 110
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 108
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 106
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 105
ILC3 in Axial Spondyloarthritis: the Gut Angle 104
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 103
"What is fuelling the immune response in systemic lupus erythematosus?" Evaluating the key metabolites driving plasmablast differentiation 102
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 102
Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review 101
Precision medicine in systemic lupus erythematosus 101
Current pharmacological treatment of idiopathic inflammatory myopathies 101
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 99
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 97
Mortality in Italian patients with rheumatoid arthritis: Evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center 97
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE? 96
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 94
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 91
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 91
Rituximab in the treatment of inflammatory myopathies: a review 90
Lung involvement in stable undifferentiated connective tissue diseases: a rheumatology perspective 88
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 87
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 83
Subclinical Pancreatitis as Onset of Systemic Lupus Erythematosus: Case Report and Review of the Literature 83
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 81
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 80
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve 78
Thrombocytopenia in the Antiphospholipid Syndrome 76
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 74
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 73
Present and novel biologic drugs in primary Sjogren's syndrome 69
Systemic lupus erythematosus and the role of the GP 67
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study 66
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: Results of the DeSScipher inception cohort study 65
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis 65
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 64
The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases 59
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview 58
Recognition and management of systemic lupus erythematosus 54
Totale 4.290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 8 24 2 8 3 35 1
2021/2022193 5 0 0 3 82 0 9 4 10 3 12 65
2022/2023485 39 3 20 14 50 29 0 23 281 1 13 12
2023/2024191 16 17 13 15 80 6 0 1 1 1 5 36
2024/2025749 1 20 4 13 99 94 91 106 63 167 65 26
2025/20262.332 91 126 146 124 257 1.588 0 0 0 0 0 0
Totale 4.290